We previously showed that skeletal myocytes of the adult rabbit do not accumulate the endoplasmic reticulum glucose-regulated protein GRP94, neither constitutively nor inducibly, at variance with skeletal myocytes during perinatal development (5). Here we show that C2C12 cells upregulate GRP94 during differentiation and, similarly to primary cultures of murine skeletal myocytes, specifically display GRP94 immunoreactivity on the cell surface. Stable transfection of C2C12 cells with grp94 antisense cDNA shows lack of myotube formation in clones displaying >40% reduction in GRP94 amount. The same result is obtained after in vivo injection of grp94-antisense myoblasts. Conversely, GRP94 overexpression is accompanied by accelerated myotube formation. Analyses of BrdU incorporation, p21 nuclear translocation, and muscle-gene expression show that muscle differentiation is not apparently affected in grp94-antisense clones. In contrast, cell-surface GRP94 is greatly reduced in grp94-antisense clones, as shown by immunocytochemistry and precipitation of cell-surface biotinylated proteins. Thus, cell-surface expression of GRP94 is necessary for maintenance of fusion competence. Furthermore, differentiating C2C12 cells grown in the presence of anti-GRP94 antibody show decreased myotube number suggesting that cell-surface GRP94 is directly involved in myoblast fusion process.-Gorza, L., and Vitadello, M. Reduced amount of the glucose-regulated protein GRP94 in skeletal myoblasts results in loss of fusion competence. FASEB J. 14, 461-475 (2000) 
cause their synthesis is enhanced in response to ER stress, namely, when extracellular glucose is low or absent, intracellular Ca 2ϩ stores are depleted, or glycosylation is inhibited (4) . Although these proteins are considered to be ubiquitously and constitutively expressed, we recently reported that GRP94 expression in rabbit skeletal muscle myofibers appears to be developmentally regulated, being easily detectable in muscle myocytes of the fetal and newborn rabbits, whereas it is not any more detectable at both mRNA and protein level in adult skeletal muscle fibers (5) . The developmentally restricted expression of grp94 gene in skeletal muscle myofibers is apparently not accompanied by corresponding changes in GRP78 amount, which does not vary between newborn and adult mammalian skeletal muscles (6) . The disappearance of both GRP94 transcript and protein in myofibers of adult skeletal muscles cannot be reversed by exposure to bacterial lipopolysaccharide (5) , which, in contrast, is effective in increasing GRP94 expression in lymphocytes in vitro (7) and in cardiac myocytes in vivo (5) . The lack of grp94 gene responsiveness in adult skeletal muscle myofibers suggested to us that GRP94 accumulation in developing skeletal muscle is devoted to important events occurring during muscle differentiation.
Several functions have been recognized for GRPs: GRP78 and GRP94 act as molecular chaperones involved in protein translocation into the ER, in their subsequent folding and assembly, and in regulating protein secretion (8) . Secondly, they play a functional role in cell survival because they exert a specific protection against Ca 2ϩ depletion stress (4, 9, 10) . Furthermore, GRP94 has been shown to participate in antigen presentation (11, 12) . Finally, GRP94 is a low affinity-high capacity Ca 2ϩ -binding protein, a property which, like chaperoning and involvement in cell protection, is in common with other ER resident proteins, such as calreticulin and protein disulfide isomerase (13, 14) . Despite such a multiplicity of functions, little is known concerning the functional role of GRPs, and of stress proteins in general, during cell differentiation (15) . Until now, knocking-out of grp78 and grp94 genes has been so far limited by the fact that a certain basal level of protein is required for cell survival (4) , and, indeed, strategies aimed to reduce transcript accumulation have been successful in demonstrating loss of protection against various stresses (9, 10) .
Given that postnatal maturation of skeletal muscle is characterized by down-regulation of the grp94 gene, we asked whether reduced amounts of GRP94 in myoblasts may affect muscle maturation. Thus, we chose to reduce GRP94 levels in a skeletal muscle cell line (C2C12, 16) by stable transfection with a vector containing rabbit grp94 cDNA sequence in antisense orientation driven by a RSV promoter. Although Ͼ40% reduction in GRP94 amount does not interfere with cell cycle withdrawal and musclespecific gene expression, it affects myotube formation. In contrast, GRP94 overexpression accelerates myotube formation.
In addition we report that control C2C12 cells and cultured primary myoblasts, but not fibroblasts isolated from the same newborn skeletal muscles, show the presence of GRP94 on the outer surface of the cell membrane. Cell surface GRP94 is strongly reduced in grp94 antisense clones; furthermore, incubation of C2 cells with anti-GRP94 antibody delays myotube formation suggesting that GRP94 localization at the cell surface plays an essential role in myotube formation.
MATERIALS AND METHODS

Tissue source and experimental protocols
One-day-old newborn and adult mice from Swiss, Balb/c, and C3H/HeJ strains and the murine muscle cell line C2C12 were used for this study. Twelve 2-month-old singeneic C3H/HeJ mice were used for in vivo injection of C2C12 cells after stable cotransfection with control or antisense grp94 and ␤-galactosidase cDNAs. Briefly, under ketamine anesthesia, 3 ϫ 10 5 cells in 30 l Dulbecco's modified Eagle's medium (DMEM) were injected per site in tibialis anterior of both legs. Muscles were excised at day 6 (nϭ6) and at day 7 (nϭ6) after cell injection, processed for the histochemical demonstration of ␤-galactosidase, and counterstained with hematoxylin and eosin, as described previously (17) .
Cell culture
Primary cultures of skeletal myocytes were prepared by pooling muscles excised from newborn mice of the same litter. In brief, muscles were minced and the cells were dispersed by treatment with 0.25 mg/ml trypsin (Sigma, St. Louis, Mo.) at 37°C. The cells were resuspended in proliferation medium [DMEM, containing 10% fetal calf serum, L-glutamine, and antibiotics (Sigma, Milan)] and preplated 20 min to remove nonmuscle cells. Unattached 1 ϫ 10 5 muscle cells were seeded on gelatinated round coverslips in 24-well Falcon plates (Becton Dickinson, Bedford, Mass.). After 24 h, cells were switched to differentiation medium [DMEM, containing 2% horse serum and 0.5 g/ml insulin, L-glutamine, and antibiotics (Sigma)].
C2C12 murine myoblast cells were cultured in proliferation medium (see above). To avoid spontaneous differentiation, the cells were not allowed to reach confluency. Differentiation was induced by replacing medium, as described for primary myoblast cultures. Stable transfectants were selected in the same media as for C2C12 added with 500 g/ml G418 (Boehringer, Mannheim, Germany).
For immunofluorescence, cells were seeded on gelatinated coverslips in 24-well plates at a density of 10,000 cells per well and grown in proliferation medium. After 24 h, cells were switched to differentiation medium for 48 h and then processed as described below.
For incubation with antibodies, 1 ϫ 10 3 C2C12 cells were seeded in 96-well culture plates (Becton Dickinson) in 150 l proliferation medium. 24 h later, medium was replaced with differentiation medium added twice a day with either 10, 5, or 2 g/well of 3C4 purified immunoglobulins or, alternatively, of comparable amounts of mouse nonimmune immunoglobulins (Sigma). Experiments were performed in triplicate and wells were examined for the presence of myotubes after 3-4 days.
For RNA extraction or homogenate preparation, cells were seeded at a density of 450,000 cells/10-cm petri dish (Becton Dikinson) in proliferation medium. Cells were either maintained in proliferation medium or switched to differentiation medium 24 h after plating, as described below, before utilization.
Probe and construct preparation
We have previously described 2.5 and 2.52 grp94 rabbit cDNA (5). Clone 2.5 was used for generation of cRNA probes for Northern blotting. Clone 2.52 was used to prepare constructs suitable for eukaryotic expression studies. In brief, sense or antisense mRNA expression was achieved ligating the 5Ј XbaI fragment of the 2.52 insert (1.1 kb in length) either in antisense or sense orientation to the NheI site of the RSV promoter of the pBK-RSV phagemid (Stratagene, La Jolla, Calif.). Antisense and sense orientation of the insert in pBK-RSV 2.5X plasmids was checked by digestion with appropriate restriction enzymes. Note that the mRNA transcribed from the sense-oriented insert lacks translational recognition signal and does not give origin to any protein.
Overexpression of GRP94 was achieved in the following way: a cDNA sequence with an open reading frame coding for a rabbit-mouse GRP94 chimeric protein of 727 amino acids was obtained by adding 3Ј to the RSV promoter a 75 bp fragment containing the Kozak consensus translation initiation sequence (18) and the signal peptide of mouse GRP94 sequence (19) (MRVLWVLGLCCVLLTFGFVRADA) obtained by PCR amplification, and thereafter the insert of the longest rabbit grp94 cDNA (2.52 clone) ablated of the 3ЈUTR.
Furthermore, in order to visualize the transfected GRP94, a sequence corresponding to a stretch of 13 amino acids containing the VSV-G epitope (20) was inserted downstream the signal peptide (pBK-RSV94-TAG8). The resulting protein is 76 amino acids shorter at the amino terminus than murine GRP94, whose length predicted by cDNA translation is 803 amino acids (19) . Sequence of pBK-RSV94-TAG8 was checked with the dideoxychain termination method as described previously (5) . An eukariotic expression construct containing the ␤-gal cDNA (17) was also prepared using the pBK-RSV phagemid as a vector.
Transfection and selection
Approximately 1 g of pBK-RSV 2.5X sense or antisense plasmids and 1.5 g of pBK-RSV94-TAG8 were linearized with DraIII and trasfected by electroporation into C2C12 cells. Linearized pBK-RSV 2.5X sense or antisense plasmids were cotransfected with 2.8 g of the NsiI-NaeI fragment of pBK RSV-␤gal (not containing neo-resistance). The 2 ϫ 10 6 cells were grown in proliferation medium and detached from plastic with trypsin. After centrifugation (10 min at 200g) cells were resuspended in 500 l of proliferation medium, mixed with the appropriate plasmid DNAs, and electroporated at 250 mV and 960 F. Electroporated cells were seeded in 96-well culture plates with proliferation medium. After 24 h, cells were transferred in selection medium (DMEM supplemented with 10% FCS and 500 g/ml G418). The medium was changed every 48 h. Drug resistant cells were cloned by limiting dilution.
Northern blotting
Total RNA was isolated from C2C12 cultures following the procedure described by Chomczynski and Sacchi (21), electrophoresed, transferred, and hybridized either with 32 Plabeled grp94 antisense cRNA and 18S RNA probes, as described previously (5) .
Antibodies
Anti-GRP94 monoclonal antibody 3C4 was obtained after immunization with a recombinant polypeptide as described previously (5) . Monoclonal anti-desmin and anti-VSV-G antibodies were purchased from Roche (Montclair, N. J.). Specificity of monoclonal anti-troponin T antibodies RV-C2 and BN-59 and anti-troponin I TI-4 has been previously described (22, 23) . Polyclonal anti-p21 and anti-erbB2 antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, Calif.). Polyclonal anti-desmin antibodies were purchased from Sigma. Monoclonal anti-integrin ␤3 subunit was obtained from Transduction (Lexington, Ky.). Peroxidase and fluorescein conjugated antibodies were provided from Dako (Glostrup, Denmark); rhodamine conjugates were provided by Cappel (Eschwege, Germany).
Western blotting
Tissue samples were homogenized in electrophoresis sample buffer, heated for 5 min in boiling water and centrifuged (15,000g) for 15 min at 4°C. For quantitative analyses, cells were homogenized in the same buffer without bromphenol blue and ␤-mercaptoethanol, and protein concentration was determined as described by Lowry et al. (24) using bovine serum albumin as standard. Equal amounts of samples were run either in 6 -12% gradient or in 10% linear polyacrylamide gel together with commercially available preparations of molecular weight standards (Bio-Rad, Richmond, Calif.) at constant amperage (5 mA), transferred to nitrocellulose, saturated with ovalbumin, and subsequently incubated with the primary antibody. Unbound antibody was removed after extensive rinses with TBST and filters were incubated with appropriate anti-immunoglobulins conjugated with peroxidase. Peroxidase activity was revealed using diaminobenzidine, as described previously (5) .
Analysis of samples obtained by streptavidin-agarose precipitation were performed on nitrocellulose blots saturated with 1% blocking reagent (Roche) in TBST using antibodies as specified in Results. Chemiluminescent substrate (Renaissance Plus; Dupont-Nen, Boston, Mass.) was used to demonstrate bound peroxidase activity in these assays.
Immunocytochemistry
Tissue cultures were fixed for 10 min at room temperature with 4% freshly prepared buffered paraformaldehyde, rinsed twice for 15 min with phosphate-buffered saline (PBS), permeabilized with cold 0.1% Triton X-100 for 5 min, and incubated with 3C4 mAb diluted 1:500 with 0.5% bovine serum albumin in PBS. Incubation was carried out in a humidified chamber at room temperature for 30 min. After 3 ϫ 10 min rinses in PBS, sections were incubated either with appropriate dilutions of secondary antibodies coupled with peroxidase and using diaminobenzidine as a substrate or with antibodies coupled with rhodamine. After immunofluorescence staining and in order to label nuclei, sections were mounted with glycerol buffered with PBS and containing 2 g/ml 4,6-diamino-2-phenylindole (DAPI; Sigma).
For surface labeling, incubation with the first antibody was carried out on unfixed cell cultures for 3 h at 4°C. Rinsing and incubation with the secondary antibody were performed at the same temperature. Cultures were then fixed with paraformaldehyde and mounted with DAPI. Control stainings were performed using in the first step nonimmune mouse immunoglobulins (1 g/ml).
For double immunofluorescence staining, cells were incubated first with 3C4 followed by goat anti-mouse immunoglobulins conjugated with rhodamine; subsequently, they were reacted with anti-desmin followed by swine anti-rabbit immunoglobulins conjugated with fluorescein and preabsorbed with mouse nonimmune immunoglobulins to eliminate interspecies cross-reactivity, as described previously (25) .
Cell proliferation assay
Cell proliferation assays were performed by the 5-bromo-2Ј-deoxy-uridine Labeling and Detection Kit III (Roche). Briefly, 1 ϫ 10 3 cells (this density was chosen in order to avoid confluence) were seeded in 96-well culture plates (Becton Dickinson) in 100 l proliferation medium. 24 h later, medium was changed; half of the cells were switched to differentiation medium, while the remaining cells received fresh proliferation medium. After 48 h, BrdU was added to the cells (with the exclusion of blanks) at 10 M final concentration and incubated for additional 6 h. Thereafter, BrdU incorporation was determined by anti-BrdU-POD Fab as indicated by the manufacturer. Extinction of the samples was measured in a Bio-Rad Novapath Microplate Reader, at 405 nm with a reference wavelength at 490 nm.
Cell surface biotinylation, precipitation, and blot assay
Cells were grown in proliferation medium to subconfluence in 10 cm petri dishes and then switched to differentiation medium for 48 -72 h. After three rinses with ice-cold PBS, plates were incubated with 3 ml PBS containing 1 mg/ml of Sulfo-NHS-LC-biotin [sulfosuccinimidyl-6-(biotinamido)hexanoate; Pierce, Rockford, Ill.] for 1-3 min at RT. The plates were rinsed three times with cold PBS and lysed with RIPA buffer (0.9 ml/plate of 1% Nonidet P-40, 0.5% sodium deoxycholate in PBS) supplemented with antiprotease inhibitors (0.2 mM phenylmethylsulfonyl fluoride, 2 g/ml each of pepstatin, leupeptin, and aprotinin; Sigma) and centrifuged. Supernatant was precleared for 1 h at 4°C using 20 l of anti-mouse immunoglobulins conjugated with agarose (Sigma).
Equal amounts of total protein lysates (120 g) were incubated overnight at 4°C with 100 l of streptavidinagarose (Pierce). The beads containing biotinylated proteins were rinsed four times with PBS in the presence of antiprotease inhibitors, then bound biotinylated proteins were eluted from the beads by boiling for 5 min in electrophoresis sample buffer and processed for gradient gel electrophoresis and Western blotting as described above. Cell lysates from nonbiotinylated samples were processed in parallel.
Statistical analysis
Quantitative densitometry was performed on Northern and Western blots of samples obtained from normal and transfected C2C12 clones. Autoradiographic and diaminobenzidine positive bands were analyzed using a Shimadzu chromatoscanner CS-930 at wavelengths of 600 and 530 nm, respectively. Densitometric profiles were cut from paper and weighed. For RNA samples, values were normalized to the corresponding amount in 18S RNA. For Western blot experiments, where identical amounts of sample total protein were used, variability among different experiments was compensated using a sample from untransfected C2C12 cells as internal reference. Statistical analysis was performed utilizing the unpaired Student's t test. Figure 2 . Distribution of GRP94 in cultured skeletal myocytes. C2C12 cells (A) and primary cultures from newborn skeletal muscle (B) were maintained in differentiation medium for 72 h and stained with anti-GRP94 antibody after fixation and permeabilization with Triton-X100. After permeabilization, GRP94 immunofluorescence is usually concentrated in proximity of the nucleus of both muscle cells (m) and skeletal muscle fibroblasts (f) (B) and appears stronger in formed myotubes (A, arrow). Panels C-H illustrate immunostaining of C2 cells (C, E) and primary muscle cultures (G) performed at 4°C without prefixation with anti-GRP94 (C, G) or nonimmune immunoglobulins (E). Panels D, F, H illustrate DAPI labeling of the same fields shown in panels C, E, G, respectively. Punctate GRP94 immunoreactivity is observed on the cell surface of C2 and on muscle cells of primary cultures (m), not on skeletal muscle fibroblasts (f, panels G, H ). Bar ϭ 20 m. 
‹
a Mean and sem of percentage of GRP94 mRNA and protein amount were evaluated on samples obtained from different 10 cm Petri dish cultures (n indicates the number of the preparations). Values obtained in cultures after 24 h in differentiation medium were used as reference for mRNA quantitation; values obtained in cultures after 48 h in differentiation medium were used as reference for protein determination.
* P Ͻ 0.002 with respect to 24 h differentiation medium values; † P Ͻ 0.0001 with respect to 48 h differentiation medium values. n.d., not determined.
RESULTS
Cell-surface GRP94 localization in primary cultures from skeletal muscle and C2C12 cells
We recently demonstrated that GRP94 accumulates in developing skeletal muscle myocytes of the rabbit (5). GRP94 expression was then investigated in vitro using both primary cultures from mouse newborn skeletal muscles and the mouse cell line C2C12. Specificity of our rabbit antisense cRNA probe for mouse grp94 mRNA was assessed by Northern blot analysis performed on C2 cell total RNA, which shows hybridization with a single mRNA species of an approximate size of 3000 nt (Fig. 1A, B) . Northern blot analysis shows that grp94 mRNA is detectable in C2 myoblasts grown in proliferative medium and switching to differentiation medium is accompanied with an ϳ75% increase in grp94 mRNA (Fig. 1A, B and Table 1 ).
Western blot analysis performed with the monoclonal antibody 3C4, which was raised using a recombinant rabbit GRP94 polypeptide (5), decorates in C2C12 cells a single 99 kDa polypeptide corresponding to mouse GRP94 (Fig. 1C) . Change in protein accumulation detected in differentiating C2 myoblasts 48 h after medium replacement parallels the increased accumulation of grp94 mRNA (Fig. 1C, D and Table 1 ).
Immunohistochemistry performed on fixed permeabilized cells shows strong punctate immunoreactivity of GRP94, which is often concentrated in proximity of the nucleus, in both growing and differentiating C2 and primary myoblasts ( Fig. 2A, B) . In primary culture no apparent difference in the cytoplasmic distribution of the staining can be observed between myocytes and fibroblasts (Fig. 2B , compare m with f ), the latter being desmin-negative in double immunostaining (not shown). Positive immunoreactivity for GRP94 is also observed on the surface of unfixed nonpermeabilized myoblasts (Fig.  2C, G) . Immunoreactivity has a granular appearance, which appears to be distributed rather homogeneously. Strikingly, no apparent immunoreactivity is detectable on cell surface of fibroblasts in primary cultures (Fig. 2G) . Control labeling of unfixed, nonpermeabilized C2 and primary skeletal muscle cells with nonimmune mouse immunoglobulins does not reveal any reactivity (Fig. 2E) .
To confirm that the immunostaining of GRP94 at the cell surface is not because of the presence of a cross-reactive protein, C2 cells maintained in differentiation medium were biotinylated and labeled proteins were precipitated with streptavidinagarose. Western blotting analysis shows that the streptavidin-bound fraction is enriched in membrane proteins such as erb-B2 and also displays GRP94 immunoreactivity, whereas no apparent immunoreactivity for cytoplasmic proteins like troponin I or T subunits is detectable in the streptavidin-bound fraction (Fig. 3) .
Antisense GRP94 mRNA affects GRP94 expression and myotube formation
To investigate more directly the role of GRP94 in developing muscle cells, C2C12 cells were stably transfected with a G418 permissive vector containing a 1,000 bp fragment of grp94 cDNA in antisense orientation under the control of the RSV promoter. Control clones were transfected with a construct containing the same grp94 cDNA in sense orientation, which could be transcribed but not translated. Relative GRP94 levels, quantified by Western blotting analysis, were determined in five different antisense and in two control clones grown in differentiation medium and normalized to GRP94 amounts observed in untransfected C2 cells (Fig. 4 and Table  2 ). Four out of five antisense clones show Ͼ40% reduction in GRP94 amount, whereas no significant change is detectable in the control clones. In every antisense clone displaying Ͻ60% GRP94 amount, no myotube formation is observed after permanence in differentiation medium, despite the fact that cells were confluent ( Table 2 and Fig. 5) . Such a finding is still observed 12 days after switching to differentiation medium. Conversely, already after 5 days in culture in differentiation medium, both untransfected C2 cells, control clones, and the antisense clone AS4D4, which contains near normal levels of GRP94, display a consistent degree of fusion, cultures being represented by a complete layer of myotubes (Fig. 5A) .
Furthermore, although growth of grp94 antisense clones in media without G418 shows the appearance of rare myotubes that probably derive from spontaneously revertant cells (not shown), no formation of myotubes was observed after in vivo transfer of two antisense clones (AS3A12 and AS1G11) (Fig. 6B) . These two clones were chosen together with the control clone S1H2 because of the additional stable integration of the RSV-lacZ construct. We injected 3 ϫ 10 5 cells of each clone in tibialis anterior of CH3/HeJ adult female mice. After either 6 or 7 days, muscles were removed and stained for the histochemical demonstration of ␤-galactosidase. Blue myotubes could be easily detected in muscles injected with the control clone (Fig. 6A) , conversely, only weakly ␤-gal positive myoblasts were detected in muscles injected with each antisense clones (Fig. 6B) .
Reduced GRP94 level does not interfere with myoblast cycle withdrawal and differentiation
We then investigated whether other fundamental steps of skeletal muscle cell differentiation such as cycle withdrawal and muscle-specific gene expression are affected in GRP94 antisense clones. In cell proliferation assays, BrdU incorporation after 48 h growth in differentiation medium was measured for untransfected C2 cells, two control clones (S1C8 and S1H2), and four grp94 antisense clones (AS3A12, AS1G11, AS1F4, and AS4F1), and values were normalized to the amount of BrdU incorporation in proliferation medium determined for each clone. Switching to differentiation medium significantly reduced BrdU incorporation in both control and grp94 antisense clones (Fig. 7) . Thus, antisense clones are responsive to the well-known inhibitory activity on DNA synthesis caused in skeletal muscle cells by serum deprivation. Furthermore, immunolabelling with anti-p21 antibodies shows that the large majority of antisense and control clone myoblasts display positive nuclear p21 staining after 2 days of growth in differentiation medium ( Table 2) . The presence of differentiation was then evaluated considering the decrease in integrin ␤3 subunit (26), the increase in desmin accumulation (27) , and the a Mean and sem of percentage of GRP94 amount were evaluated on whole homogenates obtained from different 10 cm Petri dish cultures maintained for 48 h in differentiable medium (n indicates the number of the preparations). Values obtained in untransfected cultures were used as reference.
b Presence of myotubes was evaluated for each clone inspecting four different wells from a 24-well plate seeded at the same density and maintained for 7 days in differentiable medium.
c Percentage of p21 positive nuclei was evaluated after 2 days growth in differentiation medium and expressed relative to the total number of nuclei counted for each clone. n.d., not determined. expression of muscle-specific genes, such as troponin T (22) . After 4 days of exposure to differentiation media, no decrease in integrin ␤3 subunit amount is observed in C2C12 cells (Fig. 8), at variance with what has been reported for human differentiating myoblasts (26) . The same result is observed in antisense (Fig. 8 ) and control clones (not shown). Conversely, increased desmin accumulation with respect to the levels displayed in proliferating medium is observed in both untransfected C2 cells (Fig. 8) , control clones (not shown), and antisense clones. Furthermore, cardiac troponin T, which is expressed by embryonic skeletal muscle (22) , accumulates in untransfected cells, antisense, and control clones only after switching to differentiation medium ( Fig.  8 and not shown) . Although variations in the total amount of desmin and cardiac troponin T were observed in different antisense clones (compare clone AS1G11 with clones AS2A2 and AS3A12), no obvious relationship apparently exists with the absence of fusion competence (see Table 2 ).
Overexpression of GRP94 is accompanied by accelerated myotube formation
We then investigated whether GRP94 overexpression influences positively myotube formation. C2C12 cells were transfected with the same G418 permissive vector modified in order to obtain the expression of a mouse-rabbit GRP94 chimera protein, which lacks Ͻ10% of the amino acid sequence of murine GRP94. Expression of recombinant GRP94 was visualized in permeabilized cells by mean of the anti-VSV-G epitope antibody (Fig. 9B) , and in three out of seven overexpressing clones GRP94 levels were significantly increased with respect to values observed in the sense clone S1C8 (83D11, PϽ0.003; 81A9, PϽ0.03; 85D9, PϽ0.005; Table 2 ). In GRP94 overexpressing clones myotube formation can be occasionally observed still in proliferation medium and even at low seeding density and is greatly accelerated with respect to C2C12 cells after exposure to differentiation medium (Fig. 9 compare A and D) . The presence of myotubes was evaluated counting the number of nuclei in terminally differentiated myoblasts identified by immunofluorescence staining for troponin T (28, 29) , in parallel cultures of untransfected, control, and overexpressing clones seeded at the same density ( Table 3) . Data show that the percentage of myotubes is higher in the GRP94 overexpressing clone 81A9, whereas no apparent difference is detectable between control and untransfected C2 cultures. Western blot analysis performed on total protein homogenates (10 g) from untransfected C2C12 and three different grp94 antisense clones, prepared from cells cultured in proliferation medium (p) and 4 days in differentation medium (d), and tested with anti-integrin ␤3 subunit (␤3), anti-desmin (DES), and anti-troponin T (TN T) antibodies. Switching to differentiation medium is accompanied by increased accumulation of desmin and expression of troponin T in both untransfected C2 cells and grp94 antisense clones, whereas no difference is observed concerning integrin ␤3 subunit immunoreactivity.
Fusion competence is related to surface GRP94 expression
Immunofluorescence analysis of cell-surface GRP94 immunoreactivity in grp94 antisense clones shows reduced signals with respect to untransfected C2 cells (Fig. 10) ; conversely, increased cell surface immunostaining is detectable on GRP94 overexpressing clones (not shown). To evaluate more precisely whether the relative amount of GRP94 localized at the cell surface in antisense clones is significantly changed with respect to the amount displayed by untransfected C2 cells, GRP94 immunoreactivity of untransfected and two different grp94-antisense clones was quantified after streptavidinagarose fractionation of cell-surface biotinylated samples. Results show that cell-surface GRP94 of both the grp94-antisense clone AS3A12 (Fig. 11) and clone AS1G11(not shown) is strongly reduced. Densitometric analysis indicates an ϳ40-fold decrease in clone AS3A12 (2.5%Ϯ1.2 se) with respect to untransfected C2C12 cells (98%Ϯ20.3 se). An additional evidence underscores the possible direct involvement of cell-surface GRP94 in muscle cell b TnT positive percentage was expressed relative to the total number of the observed nuclei, which corresponded to 3000 for each category.
TABLE 3. Percentage of nuclei in myotubes in cultures of untransfected C2C12, grp94 control (S1H2), and GRP94 overexpressing (81A9) clones maintained for 30 h in differentiation medium
fusion. Untransfected C2C12 cells were incubated in differentiation medium with the addition of the anti-GRP94 antibody 3C4. Results show reduced myotube formation in the presence of repeated addition (twice a day for three and a half days) of 5-10 g/ml of anti-GRP94 antibody, whereas no change in the percentage of myotubes is detectable when different amounts of nonimmune mouse immunoglobulins were added to parallel cultures ( Fig.  12 and Table 4 ).
DISCUSSION
Our previous investigation showed that GRP94 expression in skeletal myocytes is developmentally regulated (5). We now provide evidence that this protein is directly involved in muscle maturation, because a reduction in cell-surface GRP94 expression is followed by hampered myotube formation. Indeed, this evidence adds a new item to the long list of functions that have been attributed to GRP94 and its cognate proteins (4) and points to the fact that GRP94 is necessary for some tissue-specific or definite biological functions for which it can not be substituted by any other related protein. . grp94 antisense clones show strongly reduced cell-surface biotinylated GRP94. Different preparations of untransfected C2C12 (U) and grp94 antisense clone AS3A12 (A) grown in differentiating medium for 48 h were cellsurface biotinylated and equal protein amounts of total cell lysate were incubated with streptavidin agarose and precipitated as described. Blots show the immunoreactivity for GRP94 on the streptavidin bound fraction.
GRP94 expression and subcellular localization in skeletal myoblasts
The presence of GRP94 characterizes immature myofibers with respect to adult skeletal myocytes in vivo (5), and, as described by this study, switching from proliferative to differentiation medium of untransformed C2 cells regulates positively grp94 mRNA accumulation and protein synthesis. The relative delay with which both GRP94 mRNA and protein accumulate after medium replacement indicates that these changes are independent from a stress-response secondary to serum deprivation; consistent with what is reported for other cell types, GRP94 cellular levels are not apparently influenced by medium composition, at variance with other ER proteins such as protein-disulfide isomerase (30) . Rather, changes in GRP94 levels appear to be related to defined functional requirements, such as immunoglobulin production (30) , thyroglobulin folding and transport (31) , and processing of lysosomal enzymes such as ␣-L-iduronidase (9) . Furthermore, in the present study we demonstrate GRP94 localization at the cell surface of cultured muscle cells by means of immunofluorescence and separation of biotinylated cell-surface GRP94. Such a localization has been convincingly shown for GRP94 only in neoplastic cells (32) , and it appears to be shared with other ER resident proteins such as calreticulin (33) . It is known that the retention signal present at the carboxyterminus of many ER resident proteins may be overcome in stress conditions and followed by secretion of the protein (34) . However, this does not appear to be the case for our primary skeletal muscle cultures; in fact, if GRP94 is secreted, labeling would be detected on the surface of any cell. Such a possibility does not explain why muscle fibroblasts, which also contain GRP94 in the ER (this work and ref 5) , do not display any signal for GRP94 on the outer cell membrane. The possibility exists that post-translational modifications such as NH 2 -terminal or carboxyl-terminal truncations may favor escape from the ER (1); however, biotinylated GRP94 did not apparently differ in molecular size from the intracellular form. Although the precise mechanism that regulates intracellular GRP94 redistribution remains to be determined, our results indicate that both GRP94 amount and targeting at the cellular b TnT positive percentage was expressed relative to the total number of nuclei counted (indicated in parentheses). The low percentage of TnT positive cells is due to the low seeding density used to facilitate cell counts.
surface appear to be crucial for differentiating muscle cells.
GRP94 expression and muscle differentiation
Myotube formation represents the final step of a highly ordered sequence of events that occur during myogenesis, beginning with cell cycle withdrawal of proliferative myoblasts and followed by the sequential activation of muscle-specific genes (28) . Our results show that the reduction in GRP94 amount observed in grp94 antisense clones does not apparently affect any of these stages, except the formation of multinucleated myotubes. No significant difference in cell cycle arrest, measured as the relative decrease in bromodeoxyuridine incorporation, was observed between grp94 antisense and control clones or untransfected C2C12 cells. Similarly, no difference was observed in the percentage of the cells expressing nuclear localization of p21 after 2 days of permanence in differentiation medium. The lack of myotube formation is certainly the more common evidence reported when describing the effects of engineering antisense muscle-specific cDNAs in muscle cells in vitro, like desmin (27) , or of knocking-out muscle-regulatory genes in vivo, like myogenin (35, 36) . In both cases, hampered myotube formation is associated with the impairment of muscle-specific gene expression, an event that should precede myoblast fusion (28) . After switching from proliferation medium to differentiation medium, both control and antisense GRP94 clones display signs of muscle-specific gene activation, like the increase in accumulation of desmin (27) and the expression of cardiac troponin T (22), albeit to variable extent. Conversely, antisense GRP94 clones showing a significantly reduced GRP94 amount do not form multinucleated myotubes either in vitro or in vivo despite of being confluent. If normal GRP94 levels are necessary for the maintenance of fusion competence, the increase of GRP94 obtained in overexpressing clones is conversely associated with accelerated myotube formation, which could be observed even at low seeding density.
Involvement of cell-surface GRP94 in muscle cell fusion
Another compelling piece of evidence concerning the involvement of GRP94 in the preservation of fusion competence is provided by the dramatic decrease of cell-surface GRP94 in antisense clones in comparison with control clones. Furthermore, the experiment that shows delayed myotube formation of untransfected C2 cells cultured in the presence of anti-GRP94 antibody strongly suggests a direct involvement of cell-surface GRP94 in myotube formation. Although the molecular details of the surface attachment of GRP94 are still unknown, GRP94 stays there either through hydrophobic interactions (1) or in connection with transmembrane proteins, some of which could also participate to myoblast fusion. Thus, our results indicate cell-surface GRP94 as a necessary component for myoblast fusion both in vitro and in vivo.
Such a conclusion may be weakened by the role played by GRP94 as molecular chaperone. Indeed, the decrease in GRP94 amount may have consequences on protein folding, favoring protein retention within the ER and eventually influencing the turn-over of unfolded proteins as well as gene expression. However, the effects on myoblast fusion because of decreased GRP94 expression cannot be explained with reduced externalization of N-cadherin or ␤ 1 integrin, because in vitro knock-out of N-cadherin and null-␤ 1 integrin muscle cells in chimeric mice have proven not to perturb muscle cell fusion (37, 38) . Similarly, changes in GRP94 amount could affect intracellular transport of proteases such as calpain, ␣-meltrin, or cathepsin B (39 -41), which exert their proteolytic activity on the extracellular matrix and are mechanistically involved in myotube formation. However, our in vivo transplantation experiments showed no appearance of myotubes from grp94 antisense clones indicating that environmental cues cannot rescue the grp94 antisense phenotype. In any case, the role played by GRP94 as a molecular chaperone does not appear to be compensated by other ER proteins. In contrast to what one would expect as a consequence of the unfolded protein response, previous observations showed that reduced up-regulation of GRP78 accompanies the lack of GRP94 increase after exposure to stress of a tumor cell line transfected with a grp94 targetedribozyme (9) . Comparable evidence for reduced GRP94 levels was described in cells engineered with grp78 antisense vectors (42) . Also, our grp94 antisense clones show a parallel reduction in the amount of GRP78 (L. Gorza and M. Vitadello, unpublished results); however, our result showing decreased myotube formation after exposure to anti-GRP94 antibody rules out a possible role for GRP78 in muscle fusion. Furthermore, at variance with GRP94, GRP78 expression in skeletal muscle fibers does not vary during development to adulthood (5, 6) . Although adult skeletal myofibers can fuse with transplanted myoblasts, as previously reported (43), here we show that adult skeletal myofibers, which express GRP78 but not GRP94, can not rescue fusion of grp94 antisense myoblasts.
The direct involvement of GRP94 in myoblast fusion implies a ligand-binding function of this pro-tein. Recent evidence obtained investigating immune response against tumors indicates that externalized GRP94 can interact with cell receptors on dendritic cells, which internalize GRP94-peptide complexes and process them to the class I antigen pathway, probably using a mannose receptor that binds to the high mannose content of GRP94 (11, 12) . Although we have not identified so far a partner for GRP94 involved in myotube formation, there is evidence that skeletal muscle cells express a mannose receptor, which corresponds to the insulin-like growth factor II receptor and appears to mediate the uptake of lysosomal enzymes, such as N-acetylgalactosamine 4-sulfatase and acid alpha-glucosidase, as shown by experiments with skeletal myoblasts engineered to correct lysosomal storage diseases (44, 45) .
In conclusion, our data reveal a new and unexpected role for GRP94 in muscle cell maturation, because reduction in GRP94 expression deeply influences myoblast competence for fusion; furthermore, we identify the cell surface as the crucial site where GRP94 participates in myotube formation.
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